Normal.dot

PB 8 of 2014

National Health (Weighted average disclosed price – main disclosure cycle) Amendment Determination 2014 (No. 1)

National Health Act 1953

I, FELICITY McNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this amendment determination under subsection 99ADB(4) and paragraph 99ADH(1)(aa) of the National Health Act 1953.

Dated 6 February 2014

FELICITY McNEILL

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

1 Name of Determination

(1) This Determination is the National Health (Weighted average disclosed price – main disclosure cycle) Amendment Determination 2014 (No. 1).

(2) This Determination may also be cited as PB 8 of 2014.

2 Commencement

This Determination commences on the day after it is registered.

3 Amendments to PB 82 of 2013

Schedule 1 amends the National Health (Weighted average disclosed price - main disclosure cycle) Determination 2013 (No.2) (PB 82 of 2013).

Schedule 1 Amendments

1] Schedule 1, After

1235

Mometasone

Ointment containing mometasone furoate
1 mg per g, 15 g

Application

Zatamil

4.52

omit:

1236	Morphine	Injection containing morphine sulfate 10 mg in 1 mL	Injection	Hospira Pty Limited	4.27
1237	Morphine	Injection containing morphine sulfate 15 mg in 1 mL	Injection	Hospira Pty Limited	4.58
1238	Morphine	Injection containing morphine sulfate 30 mg in 1 mL	Injection	Hospira Pty Limited	5.82
1239	Morphine	Injection containing morphine sulphate 10 mg in 1 mL (with preservative)	Injection	Morphine Sulphate Wockhardt	8.53
1240	Morphine	Injection containing morphine tartrate 120 mg in 1.5 mL	Injection	Hospira Pty Limited	17.64

Note

1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.comlaw.gov.au/Home.